🇺🇸 FDA

Drug profile · INN

adalimumab

FYZOCLAD

approved L04AB04
US status
approved
Patents linked
8
News articles
1

Quick answer

adalimumab (FYZOCLAD) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

Key facts

INN adalimumab
Brand FYZOCLAD
Formulation VIAL
ATC code L04AB04

Related patents

Search patents →

  1. US 12246064

    Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexate

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11229702

    High concentration formulations of adalimumab

    Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10799585

    Stable aqueous formulations of adalimumab

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10786566

    Stable aqueous formulations of adalimumab

    Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10780163

    Stable aqueous formulations of adalimumab

    Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10772959

    Stable aqueous formulations of adalimumab

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10772960

    Stable aqueous formulations of adalimumab

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10722579

    Stable aqueous formulations of adalimumab

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is adalimumab?

adalimumab (FYZOCLAD) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

What is the brand name for adalimumab?

FYZOCLAD is a marketed brand name for adalimumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of adalimumab?

adalimumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.